Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Bacillus Calmette-Guérin (BCG) in combination with PANVAC™ vs. BCG alone in adults with high-grade BCG-refractory non-muscle-invasive bladder cancer

Urologic Oncology Seminars and Original Investigations(2025)10.1016/j.urolonc.2025.06.006Source: DataRank Database

Bacillus Calmette-Guérin (BCG) in combination with PANVAC™ vs. BCG alone in adults with high-grade BCG-refractory non-muscle-invasive bladder cancer is a research paper published in Urologic Oncology Seminars and Original Investigations (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: greenTopics (16)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (25)

Alon Lazarovich ORCID,Ragheed Saoud ORCID,Aaron Dahmen ORCID,Samuel Tremblay ORCID,Siobhan Telfer

Live enrichment

PubMed:40781051

National Institutes of Health National Cancer Institute

Grant: ZIABC011528

Intramural NIH HHS

Grant: Z99 CA999999

Bavarian Nordic

American Society of Clinical Oncology

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12547981/pdf/nihms-2090849.pdf

publisherhttps://api.elsevier.com/content/article/PII:S1078143925002224?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1078143925002224?httpAccept=text/plain

MeSH Terms

HumansNeoplasm InvasivenessNeoplasm Recurrence, LocalBCG VaccineAdjuvants, ImmunologicProspective StudiesAdultAgedMiddle AgedFemaleMaleUrinary Bladder NeoplasmsNon-Muscle Invasive Bladder Neoplasms

Keywords

BCGNon-muscle Invasive Bladder CancerPanvac™